Information for Authors
These guidelines are in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”. The complete document appears at (www.icmje.org).
The “Bulletin de la Société des Sciences Médicales du Grand Duché de Luxembourg, (Bull. Soc. Sci. Med.)” is published 2 or 3 times a year and accepts articles in French, German or English. All articles must be preceded by an English abstract. The authors are invited to submit one original manuscript and a duplicate, typed in double-space with one set of original figures. Every manuscript has to be accompanied by an electronic version (preferentially Microsoft Word) of the text on floppy disk, zip disk, CD-ROM or directly submitted via Email (firstname.lastname@example.org). Three to 10 key words should be added to the bottom of the abstract page. The electronic submission of figures and photographs is encouraged.
Please address all submissions to the editorial office at: c/o Dr Guy Berchem Service d’Hémato Cancérologie, Centre Hospitalier de Luxembourg, 4, rue Barblé, L-1210, Luxembourg, Luxembourg.
A covering letter signed by all authors should identify the person (with the address, telephone number, and e-mail address) responsible for negotiations concerning the manuscript; the letter should make it clear that the final manuscript has been seen and approved by all authors.
Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product.
Copyright in any contribution is owned by the Société des Sciences Médicales du Grand Duché de Luxembourg.
References must numbered consecutively as they are cited. The style of references is that of Index Medicus. List all authors when there are six or fewer; when there are seven or more, list the first three, then “et al.” The following is a sample reference:
- Lahita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med 1979;301:1382-5.
Figures should be professionally designed. Electronic submissions are requested. If photographs of patients are used, either the subjects should not be identifiable or their pictures must be accompanied by written permission to use the figure.
For drugs, generic names should generally be used. Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the Bulletin for reproduction.
Manuscripts are examined by the editorial staff and are usually sent to outside reviewers.